Lazard Asset Management
HIMS icon

Lazard Asset Management’s Hims & Hers Health HIMS Stock Holding History

Lazard Asset Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Sell
12,048
-373
-3% -$8.81K ﹤0.01% 1564
2025
Q4 		$403K Sell
12,421
-8,685
-41% -$372K ﹤0.01% 1443
2025
Q3 		$1.2M Sell
21,106
-3,033
-13% -$155K ﹤0.01% 1080
2025
Q2 		$1.2M Sell
24,139
-4,361
-15% -$197K ﹤0.01% 1224
2025
Q1 		$841K Buy
28,500
+6,926
+32% +$257K ﹤0.01% 1272
2024
Q4 		$520K Sell
21,574
-211,692
-91% -$5.24M ﹤0.01% 1354
2024
Q3 		$4.29M Buy
233,266
+71,678
+44% +$1.28M 0.01% 674
2024
Q2 		$3.26M Buy
+161,588
New +$2.69M ﹤0.01% 774
2023
Q1 		– Sell
-9,149
Closed -$58K – 2408
2022
Q4 		$58K Hold
9,149
– – ﹤0.01% 1733
2022
Q3 		$51K Buy
+9,149
New +$55.1K ﹤0.01% 1792

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Lazard Asset Management's HIMS Position: Q1 2026 in Review

Lazard Asset Management reduced its Hims & Hers Health (HIMS) stake by 3% in Q1 2026, selling an estimated $8.81K and leaving 12,048 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Lazard Asset Management first reported a position in HIMS in Q3 2022 and has held it in 10 quarters since. The position peaked at $4.29M in Q3 2024. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Lazard Asset Management held 12,048 shares of Hims & Hers Health worth $250K as of Q1 2026.
  • Lazard Asset Management sold 373 Hims & Hers Health shares in Q1 2026, an estimated $8.81K.
  • Hims & Hers Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1564 holding.
  • Lazard Asset Management first reported a position in Hims & Hers Health in Q3 2022 and has held it in 10 quarters since.
  • Lazard Asset Management's Hims & Hers Health position peaked at $4.29M in Q3 2024.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.